It was found in clinical cohorts that the degree of rise in blood PAI-1 levels has been linked to the degree of liver steatosis (Barbato et al., 2009), inflammation, and fibrosis (Verrijken et al., 2014). Here, SERPINE1 is linked to fatty liver disease.